Authors: Unger, EF Goncalves, L Epstein, SE Chew, EY Trapnell, CB Cannon, RO Quyyumi, AA Stine, A Loscalzo, F Stiber, JA

Citation: Ef. Unger et al., Effects at a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris, AM J CARD, 85(12), 2000, pp. 1414-1419

Authors: Jacobson, JM Spritzler, J Fox, L Fahey, JL Jackson, JB Chernoff, M Wohl, DA Wu, AW Hooton, TM Sha, BE Shikuma, CM MacPhail, LA Simpson, DM Trapnell, CB Basgoz, N

Citation: Jm. Jacobson et al., Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection, J INFEC DIS, 180(1), 1999, pp. 61-67

Authors: Witter, FR Barditch-Crovo, P Rocco, L Trapnell, CB

Citation: Fr. Witter et al., Duration of vaginal retention and potential duration of antiviral activityfor five nonoxynol-9 containing intravaginal contraceptives, INT J GYN O, 65(2), 1999, pp. 165-170

Authors: Barditch-Crovo, P Trapnell, CB Ette, E Zacur, HA Coresh, J Rocco, LE Hendrix, CW Flexner, C

Citation: P. Barditch-crovo et al., The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive, CLIN PHARM, 65(4), 1999, pp. 428-438

Authors: Trapnell, CB Donahue, SR Collins, JM Flockhart, DA Thacker, D Abernethy, DR

Citation: Cb. Trapnell et al., Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone, CLIN PHARM, 64(6), 1998, pp. 597-602